According to the last estimations, about 415 million adults currently suffer from diabetes, and this number is expected to rise to 642 million by 2040 (Ogurtsova et al., 2019).
The ordinary management of type 2 diabetes mellitus (T2DM) includes lifestyle modulations and oral hypoglycemic drugs, insulin or combination between both (Chatterjee et al., 2017).